Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Nov 27.
Published in final edited form as: J Am Chem Soc. 2013 Nov 13;135(47):17707–17710. doi: 10.1021/ja409663q

Transforming Suzuki-Miyaura Cross-Couplings of MIDA Boronates into a Green Technology: No Organic Solvents

Nicholas A Isley a, Fabrice Gallou b, Bruce H Lipshutz a,*
PMCID: PMC4019934  NIHMSID: NIHMS540436  PMID: 24224801

Abstract

New technology has been developed that enables Suzuki-Miyaura couplings involving widely utilized MIDA boronates to be run in water as the only medium, mainly at room temperature. The protocol is such that no organic solvent is involved at any stage; from the reaction through to product isolation. Hence, using the E Factor scale as a measure of greenness, the values for all of these cross-couplings approach zero.


As illustrated in a review by Snieckus and Colacot tracing the development of Pd-catalyzed cross-coupling reactions leading up to the Nobel Prizes in 2010, the Suzuki-Miyaura coupling was the most heavily used among these name reactions in the last decade…by far.1 Notwithstanding its extraordinary popularity,2 such highly valued C-C bond-forming processes,3 typically run under homogeneous conditions, come with an associated heavy price from the environmental perspective. Oftentimes conditions for such couplings involve mixed, aqueous solvent systems (that make solvent recovery costly), excess of a coupling partner, and heat to drive reactions to completion. Moreover, boronic acids or their boronate derivatives oftentimes afford byproducts resulting from homocoupling or protio-quenching.2 This material is in addition to the solvents used that make up, in general, the vast majority of organic waste produced by the chemical enterprise.4

One addition to the portfolio of organoboron intermediates that has found widespread acceptance5,6 in organic synthesis involves N-methyliminodiacetic acid (MIDA) boronates, developed extensively by Burke.7 They offer several positive features associated with their use, including air stability and crystallinity, two virtues that the pharmaceutical industry, in particular, finds appealing. With notoriously unstable 2-heteroaromatic substituted systems, slow release to their corresponding boronic acids allows for couplings that otherwise have a history of either limited utility or complete failure.8

Along with these properties, however, come their attendant limitations and/or associated disadvantages that are nontrivial, especially from the standpoint of “greenness.”4b Aside from the typical conditions that rely on a large excess of base (5-7 equiv) and heat (60-100 °C) to gradually release the corresponding boronic acids, and the low molarities involved (0.01-0.13 M), the solvent systems characteristic of these couplings are partially aqueous.8,9 In some cases, the requirement for a solvent such as DMF makes the coupling highly undesirable from a safety, health, and environmental perspective.8b And just as certain organic solvents have been essentially removed from use (e.g., benzene and CCl4), and others such as chlorinated solvents discouraged, so is DMF apparently destined to realize a similar fate.10 Hence, it behooves the synthesis community to work towards not only reliance on safer solvents, but on greener solvents. Indeed, this goal is a priority in most industrial circles, including the Pharmaceutical Roundtable associated with the ACS Green Chemistry Institute.11

Our efforts of late have focused on development of alternative, non-traditional approaches to reactions that are heavily utilized by both academic and industrial labs worldwide. The goal continues to be to “get organic solvents out of organic reactions,” utilizing nanoparticles composed of environmentally benign amphiphiles that allow cross-couplings and related metal-mediated reactions to take place in water, and without heating or cooling.12 In this report, we disclose new technology that enables MIDA boronates to participate in Suzuki-Miyaura couplings where the required release of boronic acids occurs in water at room temperature (23 °C). Indeed, the overall process, including workup, can be done in the complete absence of organic solvents. Based on the most commonly employed yardstick of Sheldon and co-workers as a measure of greenness, therefore, these reactions take place with associated E Factors approaching zero.4b,13

graphic file with name nihms540436u1.jpg

An initial coupling involving a 1:1 stoichiometry of p-tolyl MIDA boronate 1 and 5-bromopyrimidine was performed in aqueous nanomicelles composed of commercially available designer surfactant TPGS-750-M14 at room temperature (Scheme 1). In the presence of palladium catalyst Pd(dtbpf)Cl2 (2 mol %), along with Et3N (3 equiv), and over a 24 hour period, the adduct could be isolated by diluting the reaction mixture with water and filtering off the desired product. Using this simple procedure, the coupling product could be isolated in 82% yield in >95% purity (by 1H NMR); alternatively, a 90% yield could be achieved using traditional methods by filtering through a plug of silica with organic solvent. This example was conducted on a gram-scale, achieving a 74% isolated yield using only 8 mL of H2O for the filtration procedure; hence, an E Factor of 6.5 if water is considered as waste.

Scheme 1.

Scheme 1

Initial coupling between a MIDA boronate and a heteroaryl bromide

Reaction variables were screened using an alkenyl MIDA boronate, where the desired product 2 was isolated in 75% yield (Scheme 2). The yield of coupling product 2 could be increased to 92% using additional MIDA boronate (1.2 equiv). Inorganic bases (e.g., Na2CO3 or K2CO3) led to <5% of the product. Other organic bases such as triisobutylamine were totally unproductive. Triethylamine, therefore, was chosen for further studies given both its low cost and effectiveness. Unlike traditional MIDA boronate couplings oftentimes run in organic media at low molarities (e.g., 0.07 M),8 a global concentration of 0.5 M was characteristic of all couplings preformed in these nanoreactors. Reactions could also be run at 1.0 M with similar yields, but on a small scale they were more difficult to monitor. Commercially available surfactants other than TPGS-750-M were evaluated, including Triton X-100, Brij 35, Solutol H15, and TPGS-1000 (vitamin E TPGS). Each led to a reasonable level of conversion under otherwise identical conditions (69-89%; see SI). Although TPGS-1000 and TPGS-750-M afforded comparable results, the former surfactant contains natural vitamin E and, therefore, is far more expensive than is TPGS-750-M.

Scheme 2.

Scheme 2

Representative cross-couplings of MIDA boronates and aryl/heteroaryl bromides in water at RT

[a] Isolated yield after filtration; product determined to be >95% pure by 1H NMR.

[b] The free boronic acid derivative was used (1 equiv).

[c] Reaction was performed in an oil bath at 40 °C.

[d] Purified by column chromatography via Biotage.

Several combinations of aryl MIDA boronates and aryl bromides, in the same 1:1 ratio, were then exposed to these conditions to assess the scope of this mild cross-coupling process. Most biaryl products illustrated in Scheme 2 were formed in high isolated yields, regardless of the electronic nature of the substituent(s) on either ring. By contrast, use of the free boronic acid, e.g., leading to product 10, afforded only a 73% yield vs. 89% using the corresponding MIDA boronate. Coupling of an N-sulfonylindole bearing a MIDA boronate at the 3-position was unexpectedly sluggish, requiring mild heating to 40 °C just to form 12 in 56% yield. Changing the nature of the coupling partner with the 3-MIDA boronate to p-bromoanisole, likewise, led to biaryl 13 in a modest 44% yield. The corresponding 2-MIDA boronate, however, showed no such problem, leading upon filtration to the desired biaryl 11 in 90% isolated yield.

Aryl/heteroaryl chlorides are also amenable to coupling under these conditions. In some cases (9, 15, 16) an increase in catalyst loading to 4 mol % was necessary to achieve full conversion (Scheme 3). Initial trails using 2 mol % catalyst led to biaryl 15 in only 45% yield, the remaining mass being unreacted starting materials. Attempts to use an excess of either partner leading to products 9 and 15 had little overall impact. Heterocyclic chlorides bearing electronically neutral, deactivated, and activated cases participate smoothly. A product such as biaryl 14 is attractive as it possesses two functional groups available for further manipulation.

Scheme 3.

Scheme 3

Representative cross-couplings of MIDA boronates and aryl/heteroaryl chlorides in water at RT

[a] Isolated yield after filtration; determined to be >95% pure by 1H NMR.

[b] 2 mol % Pd catalyst.

[c] Purified by column chromatography via Biotage.

[d] Performed in an oil bath at 40 °C.

Interestingly, there is no reported study on couplings of aryl bromides with MIDA boronates. Nonetheless, the underlying presumption is oftentimes that since aryl chlorides react to afford good isolated yields of biaryls, such will be the case with aryl bromides. However, we have previously observed, e.g., that conditions telescoped for Miyaura borylations of chlorides do not translate to bromides,[8c] and this situation appears to apply as well to MIDA boronates. As illustrated in Table 1, the coupling reaction under micellar conditions involving an aryl bromide gave a high yield of product 7. Switching to literature conditions[8a] as to the source of Pd, ligand, and solvent (aqueous dioxane) gave poor results (27%). Even by increasing the amount of Pd, ligand, and base, as prescribed for aryl chlorides in a dioxane/water mix,[8a] only a modest yield (60%) was obtained. The same trend holds with aryl chlorides, leading to biaryls 15 and 16.

Table 1.

Comparison reactions conducted at RT for 24 h.

reaction conditions 7[a] 15[a] 16[a]
PdCl2(dtbpf) (2 mol %), Et3N (3 equiv) 2 wt. % TPGS-750-M/H2O (0.5 M), RT 99% 92%[b] 53%[b]
Pd(OAc)2 (2 mol %), SPhos (2 mol %) dioxane: H2O (5:1), K3PO4 (3 equiv), RT 27% 12%[b] trace[b], 82%[c]
Pd(OAc)2 (5 mol %), SPhos (10 mol %) dioxane: H2O (5:1), K3PO4 (7.5 equiv), RT 60% 24% 32%
[a]

Isolated yield

[b]

4 mol % PdCl2(dtbpf)

[c]

Recovered Ar-Cl

[c]

Following filtration of the diluted reaction mixture leading to product isolation, the aqueous filtrate can be recycled. As illustrated in Scheme 4, once an initial coupling is completed (e.g., to give 5, 6, or 7; for additional substrates, see SI), each product can be isolated by the dilu- tion/filtration protocol. Upon addition of TPGS-750-M so as to bring its level back to 2 weight percent, the aqueous solution could be recycled to regenerate biaryls 5 and 7, which were again isolated using the same dilution/-filtration sequence. Clearly, the palladium catalyst must be retained in the aqueous phase, in all likelihood assisted by the MIDA salt acting as ligand.15,16 Each of these products was formed with an associated E Factor approaching zero.

Scheme 4.

Scheme 4

Sequence for organic solvent-free Suzuki-Miyaura reactions: couple/filter/recycle

One application of this green chemistry focuses on the sartan family of drugs, e.g., valsartan (Diovan), which is therapeutically useful in treating congestive heart failure and high blood pressure (Scheme 5).17 The biaryl core is a common intermediate and should be derivable from a cross-coupling between 4-tolyl MIDA boronate and 2-bromobenzonitrile. Indeed, biaryl product 17 could be obtained in water at room temperature uneventfully in 92% isolated yield. 2-Chlorobenzonitrile can also be utilized as a coupling partner, albeit with mild heating to 40 °C, to arrive at 17 in essentially quantitative isolated yield.

Scheme 5.

Scheme 5

Synthesis of the biaryl core within valsartan

Lastly, a 2-pyridyl MIDA boronate has been tested to determine whether this class of particularly challenging coupling partners might be amenable to micellar catalysis. The 2-pyridyl subunit is especially common in pharmaceuticals,18 natural products,19 and materials.20 Although only a single example (18; Scheme 6) has as yet been screened, it reacted with remarkable facility with both an electron-rich and electron-poor aryl halide. Biaryls 19 and 20 were formed in good isolated yields using stoichiometric amounts of each partner, in water at 40 °C. By contrast, the traditional method includes half an equivalent of copper in the pot,21 an alcohol additive, an excess of MIDA boronate, and is run in DMF at 100 °C.8b

Scheme 6.

Scheme 6

Preliminary examples using a 2-pyridyl MIDA boronate in Suzuki-Miyaura couplings in water

[a] The coupling partner was the corresponding aryl bromide.

[b] Isolated yield after filtration procedure; determined to be >95% pure by 1H NMR.

[c] The coupling partner was the corresponding aryl chloride.

In summary, nanoreactors composed of an engineered surfactant in water enable Suzuki-Miyaura couplings involving MIDA boronates to be run efficiently in the complete absence of organic solvents using a simple couple/filter/recycle sequence. The huge excesses of heavy, inorganic bases in reaction mixtures consisting of water and organic solvents that require heating in these traditional couplings can now be replaced by very mild and green conditions. Further studies on couplings involving a variety of 2-pyridyl MIDA boronates of high relevance to the pharmaceutical industry are in progress and will be reported in due course.

Supplementary Material

1_si_001

Acknowledgments

Financial support provided by the NIH (GM 86485) is warmly acknowledged with thanks.

Footnotes

Supporting Information

Detailed experimental procedures, analytical and spectral data for all new compounds are contained within. This material is available free of charge via the Internet at http://pubs.acs.org.

The authors declare no competing financial interests.

References

  • 1.Johansson Seechurn CCC, Kitching MO, Colacot TJ, Snieckus V. Angew Chem Int Ed. 2010;51:5062–5085. doi: 10.1002/anie.201107017. [DOI] [PubMed] [Google Scholar]
  • 2.Torborg C, Beller M. Adv Synth Catal. 2009;351:3027–3043. [Google Scholar]
  • 3.(a) Hall DG. Boronic Acids. 2. Wiley-VCH; Weinheim, Germany: 2011. [Google Scholar]; (b) Miyaura N, Suzuki A. Chem Rev. 1995;95:2457. [Google Scholar]
  • 4.(a) Dunn P, Henderson R, Mergelsberg I, Wells A. Collaboration to Deliver a Solvent Selection Guide for the Pharmaceutical Industry Moving towards Greener Solvents for Pharmaceutical Manufacturing - An Industry Perspective. College Park, Maryland: ACS Green Chemistry Institute® Pharmaceutical; Jun 23–25, 2009. http://acs.confex.com/acs/green09/recordingredirect.cgi/id/510. [Google Scholar]; (b) Sheldon RA, Arends IWCE, Hanefeld U. Green Chemistry and Catalysis. Wiley-VCH; Weinheim, Germany: 2007. [Google Scholar]
  • 5.For patents, see: Amgen Inc.; USA: US 20100273764 A1 20101028 From U S Pat Appl Publ. 2010. Abbott Laboratories; USA: WO 2012129491 A1 20120927 From PCT Int Appl. 2012. Hoffmann-La F, Roche AG. Switz: WO 2012147518 A1 20121101 From PCT Int Appl. 2012. Mochida Pharmaceutical Co., Ltd.; Japan: WO 2012147518 A1 20121101 From PCT Int Appl. 2012. WO 2012046869 A1 20120412 From PCT Int Appl. 2012. WO 2011078371 A1 20110630 From PCT Int Appl. 2011
  • 6.For literature from industry, see: Grob JE, Nunez J, Dechantsreiter MA, Hamann LG. J Org Chem. 2011;76:4930–4940. doi: 10.1021/jo2005928.Grob JE, Nunez J, Dechantsreiter MA, Hamann LG. J Org Chem. 2011;76:10241–10248. doi: 10.1021/jo201973t.Grob JE, Dechantsreiter MA, Tichkule RB, Connolly MK, Honda A, Tomlinson RC, Hamann LG. Org Lett. 2012;14:5578–5581. doi: 10.1021/ol302702q.
  • 7.Gillis EP, Burke MD. Aldrichimica Acta. 2009;43:17. [PMC free article] [PubMed] [Google Scholar]
  • 8.(a) Knapp DM, Gillis EP, Burke MD. J Am Chem Soc. 2009;131:6961–6963. doi: 10.1021/ja901416p. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Dick GR, Woerly EM, Burke MD. Angew Chem Int Ed. 2012;51:2667–2672. doi: 10.1002/anie.201108608. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Lipshutz BH, Moser R, Voigtritte KR. Isr J Chem. 2010;50:691–695. doi: 10.1002/ijch.201000045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.(a) Burns AR, McAllister GD, Shanahan SE, Taylo RJK. Angew Chem Int Ed. 2010;49:5574–5577. doi: 10.1002/anie.201002416. [DOI] [PubMed] [Google Scholar]; (b) Fujita K, Matsui R, Suzuki T, Kobayashi S. Angew Chem Int Ed. 2012;51:7271–7274. doi: 10.1002/anie.201203093. [DOI] [PubMed] [Google Scholar]; (c) Brak K, Ellma JA. Org Lett. 2010;12:2004–2007. doi: 10.1021/ol100470g. [DOI] [PubMed] [Google Scholar]
  • 10.(a) Laird T, editor. Org Process Res Dev. 2012;16:1–2. doi: 10.1021/op2002613. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Dunn PJ. In: Pharmaceutical Process Development. Blacker JA, Williams MT, editors. Chapter 6 Royal Society of Chemistry; London: 2011. [Google Scholar]; (c) Jimenez-Gonzales C, Constable DJ. Green Chemistry and Engineering: A Practical Approach. Wiley; New York: 2011. [Google Scholar]; (d) Constable DJC, Dunn PJ, Hayler JD, Humphrey GR, Leazer JL, Linderman RJ, Lorenz K, Manley J, Pearlman BA, Wells A, Zaks A, Zhang TY. Green Chem. 2007;9:411. [Google Scholar]
  • 11.(a) Bryan MC, Dillon B, Hamann LG, Hughes GJ, Kopach ME, Peterson EA, Pourashraf M, Raheem I, Richardson PF, Richter DT, Sneddo HF. J Med Chem. 2013;56:6007–6021. doi: 10.1021/jm400250p. [DOI] [PubMed] [Google Scholar]; (b) Kemeling GM. ChemSusChem. 2012;5:2291–2292. doi: 10.1002/cssc.201200873. [DOI] [PubMed] [Google Scholar]; (c) Watson WJW. Green Chem. 2012;14:251–259. [Google Scholar]; (d) Ritte SK. Pharma Strives for Green Goals. Chem Eng News. 2012 May 28;90(22):20–24. [Google Scholar]
  • 12.Lipshutz BH, Ghorai S. Aldrichimica Acta. 2012;43:3.. Lipshutz BH, Ghorai S. Aldrichimica Acta. 2008;41:59.. Lipshutz BH, Ghorai S, Leong WWY, Taft BR. J Org Chem. 2011;76:5061. doi: 10.1021/jo200746y., and references therein. Lipshutz BH, Ghorai S, Abela AR, Moser R, Nishikata T, Duplais C, Krasovskiy A. J Org Chem. 2011;76:4379. doi: 10.1021/jo101974u.
  • 13.Lipshutz BH, Isley NA, Fennewald JC, Slack ED. Angew Chem Int Ed. 2013;52:10592. doi: 10.1002/anie.201302020., and references therein. (b) Our E Factor calculations take organic solvent only into consideration as waste.
  • 14.Aldrich catalog numbers 733857 and 763918.
  • 15.Report of MIDA acting as a ligand on palladium: Smith BB, Sawyer DT. Inorg Chem. 1968;7:1526.
  • 16.The catalyst is clearly soluble within our surfactant solution only with the addition of MIDA. Additionally, the Pd content within the product was nearly 8 times lower if MIDA was employed in the filtration procedure compared to its free boronic acid derivative. See SI for details and pictures.
  • 17.(a) Pandarus V, Desplantier-Giscard D, Gingras G, Beland F, Ciriminna R, Pagliaro M. Org Process Res Dev. 2013 doi: 10.1021/op400118f. in press. [DOI] [Google Scholar]; (b) Wexler RR, Greenlee WJ, Irvin JD, Goldberg MR, Prendergast K, Smith RD, Timmermans PBMWM. J Med Chem. 1996;39:625–656. doi: 10.1021/jm9504722. [DOI] [PubMed] [Google Scholar]
  • 18.DeGoey DA, Grampovnik DJ, Flentge CA, Flosi WJ, Chen H-J, Yeung CM, Randolph JT, Klein LL, Dekhtyar T, Colletti L, Marsh KC, Stoll V, Mamo M, Morfitt DC, Nguyen B, Schmidt JM, Swanson SJ, Mo H, Kati WM, Molla A, Kempf DJ. J Med Chem. 2009;52:2571–2586. doi: 10.1021/jm900044w. [DOI] [PubMed] [Google Scholar]
  • 19.(a) Aida W, Ohtsuki T, Li X, Ishibashi M. Tetrahedron. 2009;65:369–373. [Google Scholar]; (b) Kubota NK, Ohta E, Ohta S, Koizumi F, Suzuki M, Ichimura M, Ikegami S. Bioorg Med Chem. 2003;11:4569–4575. doi: 10.1016/s0968-0896(03)00526-1. [DOI] [PubMed] [Google Scholar]
  • 20.Havas F, Leygue N, Danel M, Mestre B, Galaup C, Picard C. Tetrahedron. 2009;65:7673–7686. [Google Scholar]
  • 21.(a) See Ref. 8, and references therein. Yamamoto Y, Takizawa M, Yu X-Q, Miyaura N. Angew Chem Int Ed. 2008;47:928. doi: 10.1002/anie.200704162.Jones NA, Antoon JW, Bowie AL, Borak JB, Stevens EP. J Heterocyclic Chem. 2007;44:363.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1_si_001

RESOURCES